Building Your Care Team and Preparing for Visits
At a Glance
People with autosomal recessive hypophosphatemic rickets benefit from one coordinated care team. An endocrinologist usually leads care, while the gene involved and treatment plan determine whether kidney, heart, hearing, dental, and orthopedic specialists are needed.
Because Autosomal Recessive Hypophosphatemic Rickets (ARHR) is an ultra-rare condition, building a care team with deep expertise in metabolic bone disease is an important step in ensuring a high quality of life and preventing complications [1][2]. You do not have to manage this entirely alone; your care may be coordinated through a rare-disease center, or via telehealth consultations with national experts.
The Core Care Team
A coordinated approach is often best, where one specialist manages the primary disorder and collaborates with others.
- The Lead Clinician: Metabolic Bone Specialist: This is typically a Pediatric or Adult Endocrinologist who specializes in rare bone diseases [3]. They coordinate the diagnosis, interpret complex FGF23 labs, and manage the delicate titration of medications [4].
- The Nephrologist: A kidney specialist is essential for monitoring how phosphate treatment affects the kidneys. They watch for nephrocalcinosis (calcium deposits) and help calculate the TmP/GFR to see how much phosphate the kidneys are wasting [5][6].
- The Geneticist/Genetic Counselor: This team helps explain the specific mutation (e.g., DMP1, ENPP1, or FAM20C), coordinates carrier testing for parents and siblings (cascade testing), discusses reproductive options, and guides the interpretation of Variants of Uncertain Significance (VUS) [7][8].
Subtype-Specific Specialists
Depending on the genetic cause of the ARHR, other specialists become part of the core team:
- Cardiologist/Vascular Specialist (Critical for ARHR2/ENPP1): Because ENPP1 mutations can cause calcium to harden in blood vessels and heart valves (ectopic calcification), a cardiologist may perform baseline and follow-up echocardiograms and blood pressure monitoring [9][10].
- Audiologist: Hearing loss is reported in both ENPP1 and DMP1 mutations, requiring regular hearing tests to catch changes early [11][12].
- Specialized Dentist: Due to the high risk of spontaneous dental abscesses and enamel defects, a dentist who understands metabolic bone disease is necessary for cleanings and early intervention [12][1].
- Orthopedic Surgeon: If bowing of the legs or other deformities significantly affect walking, an orthopedic surgeon experienced in “guided growth” or corrective bone surgery (osteotomy) should be consulted [13][14].
Preparing for Your First Appointment
To make the most of your first consultation, you should arrive with your “medical story” fully organized. Specialists need the original data, not just summaries.
Essential Records to Bring:
- Genetic Reports: The full, multi-page report from the testing laboratory. This contains the exact name of the mutation and the gene involved, which dictates the monitoring plan [7].
- Chronological Labs: A table or list of blood phosphate, calcium, Alkaline Phosphatase, PTH, and Vitamin D levels over time.
- Original Imaging: Ask for your X-rays, renal ultrasounds, and echocardiograms to be provided on a CD or through a digital sharing portal. Radiologists specializing in rare bone disease may want to re-read the original images [14][10].
- Paired Lab Data: If possible, bring results where blood and urine samples were taken at the same time (ideally first thing in the morning), as these are required to accurately calculate phosphate wasting (TmP/GFR) [6].
Vetting Your Specialist
Don’t be afraid to interview your potential doctor. In the world of rare disease, you need a partner who is willing to learn and collaborate. A good specialist should be able to explain how your specific mutation (like ENPP1) changes their treatment approach compared to more common forms of rickets like XLH [9][11]. If they have never treated ARHR, ask if they are willing to consult with national experts at major metabolic bone centers [1].
Common questions in this guide
Which doctors are usually involved in ARHR care?
What records should I bring to an ARHR specialist visit?
Why does ARHR care include a kidney specialist?
What extra monitoring may be needed with an ENPP1 mutation?
How can I find an experienced ARHR doctor?
What genetic information should my care team review?
Questions For You
Answer a question to get research tailored to you. Your answers are private.
Get notified when new evidence is published on Autosomal recessive hypophosphatemic rickets.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Are you comfortable coordinating my (or my child's) care with specialists in cardiology, nephrology, and dentistry who understand this specific gene mutation?
- 2.How many patients with FGF23-mediated disorders like XLH or ARHR do you currently manage in your practice?
- 3.Do you have experience calculating TmP/GFR and interpreting 'inappropriately normal' FGF23 results in the context of low blood phosphate?
- 4.In the case of ENPP1 deficiency, what is your protocol for monitoring for vascular calcification while on phosphate therapy?
- 5.Which reference laboratory do you use for genetic testing and FGF23 assays, and are they experienced in rare metabolic bone disorders?
- 6.Can you explain your approach to transitioning care from pediatric to adult specialists as my child grows?
References
References (14)
- 1
Consensus Recommendations for the Diagnosis and Management of X-Linked Hypophosphatemia in Belgium.
Laurent MR, De Schepper J, Trouet D, et al.
Frontiers in endocrinology 2021; (12()):641543 doi:10.3389/fendo.2021.641543.
PMID: 33815294 - 2
Optimizing diagnosis and management of patients with ENPP1 deficiency: an expert opinion.
Bruno I, De Sanctis L, Foligno NE, et al.
Journal of endocrinological investigation 2026; doi:10.1007/s40618-026-02843-1.
PMID: 41770448 - 3
Clinical practice recommendations for the diagnosis and management of X-linked hypophosphataemia.
Haffner D, Emma F, Eastwood DM, et al.
Nature reviews. Nephrology 2019; (15(7)):435-455 doi:10.1038/s41581-019-0152-5.
PMID: 31068690 - 4
Multidisciplinary patient care in X-linked hypophosphatemic rickets: one challenge, many perspectives.
Raimann A, Mindler GT, Kocijan R, et al.
Wiener medizinische Wochenschrift (1946) 2020; (170(5-6)):116-123 doi:10.1007/s10354-019-00732-2.
PMID: 31993875 - 5
Response of the ENPP1-Deficient Skeletal Phenotype to Oral Phosphate Supplementation and/or Enzyme Replacement Therapy: Comparative Studies in Humans and Mice.
Ferreira CR, Kavanagh D, Oheim R, et al.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2021; (36(5)):942-955 doi:10.1002/jbmr.4254.
PMID: 33465815 - 6
Tubular phosphate transport: a comparison between different methods of urine sample collection in FGF23-dependent hypophosphatemic syndromes.
Arcidiacono GP, Camozzi V, Zaninotto M, et al.
Clinical chemistry and laboratory medicine 2024; (62(6)):1126-1132 doi:10.1515/cclm-2023-1292.
PMID: 38295343 - 7
Phenotypic diversity in autosomal recessive hypophosphatemic rickets type 2.
Al Qanoobi M, Al Badi M, Al Sinani A, Mughal MZ
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2026; (41(7)):705-709 doi:10.1093/jbmr/zjag029.
PMID: 41665285 - 8
First report in Argentina of a pathogenic DMP1 variant associated with autosomal recessive hypophosphatemic rickets.
Bastida G, Ramírez F, Exeni G, et al.
Archivos argentinos de pediatria 2023; (121(2)):e202202682 doi:10.5546/aap.2022-02682.eng.
PMID: 36315908 - 9
Autosomal recessive hypophosphatemic rickets type 2 (ARHR2): Is phosphate supplementation safe?
Munteanu M, Rutsch F, Nitschke Y, et al.
Bone 2026; (202()):117698 doi:10.1016/j.bone.2025.117698.
PMID: 41176198 - 10
Autosomal recessive hypophosphatemic rickets type 2 due to ENPP1 deficiency (ARHR2).
Edouard T, Linglart A
Archives de pediatrie : organe officiel de la Societe francaise de pediatrie 2024; (31(4S1)):4S27-4S32 doi:10.1016/S0929-693X(24)00154-4.
PMID: 39343470 - 11
Prospective phenotyping of long-term survivors of generalized arterial calcification of infancy (GACI).
Ferreira CR, Hackbarth ME, Ziegler SG, et al.
Genetics in medicine : official journal of the American College of Medical Genetics 2021; (23(2)):396-407 doi:10.1038/s41436-020-00983-0.
PMID: 33005041 - 12
Expanding the Autosomal Recessive Hypophosphatemic Rickets Type I Carrier Phenotype and Adult Treatment with Burosumab.
Sawalha NA, Sampaio ML, Liu D, et al.
Calcified tissue international 2026; (117(1)).
PMID: 41820620 - 13
Case Report and Review of Literature: Autosomal Recessive Hypophosphatemic Rickets Type 2 Caused by a Pathogenic Variant in ENPP1 Gene.
Choe Y, Shin CH, Lee YA, et al.
Frontiers in endocrinology 2022; (13()):911672 doi:10.3389/fendo.2022.911672.
PMID: 35966073 - 14
Autosomal Recessive Hypophosphatemic Rickets Type 2 Associated with a Novel ENPP1 Variant in a Taiwanese Girl
Lin HY, Lee NC, Melody Tsai MJ, et al.
Journal of clinical research in pediatric endocrinology 2026; (18(Suppl 1)):6-11 doi:10.4274/jcrpe.galenos.2024.2024-3-8.
PMID: 39012089
This page is for informational purposes only and does not constitute medical advice. Your ARHR care team can tailor specialist referrals and monitoring to your diagnosis, genetic findings, and treatment.